Fritextsökning
Innehållstyper
-
Introducing ZEISS arivis Pro 4.2
Your solution for advanced image analysis and visualization.
-
”We need compatibility“
Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
Radioactive tracer to measure effect of drug towards Crohn’s disease
A radioactive tracer developed by Astra Zeneca and the Karolinska Institutet may play a major role for patients with Crohn's disease. That is the belief of Mari...
-
Are you curious about volume imaging for very large samples?
Exciting ZEISS Webinar!
-
Assignment: Facilitate the retention of foreign researchers
A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.
-
Storvarsel på Hansa Biopharma – en femtedel kan förlora jobbet
Hansa Biopharma omorganiserar och minskar personalstyrkan med cirka 20 procent, vilket väntas spara 40–50 miljoner kronor per år.
-
Tablet treatment for hair loss approved in the USA
The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.
-
ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics
Live imaging with uniform super-resolution in all spatial dimensions.
-
Omdiskuterade cancerkliniken Docrates öppnar i Sverige
Docrates Cancersjukhus i Finland har mött både ris och ros för sina metoder. Nu öppnar cancerkliniken i Stockholm.
-
Optimize Courier SUPPLIERS (DISTRIBUTORS)
-
KI’s freezer fiasco investigated: A chain of failures
A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...
-
The new ZEISS Celldiscoverer 7 has been launched
Adaptable automation for advanced workflows.
-
Abbvie flyttar in i Forskaren
Elekta, Astra Zeneca och ett tiotal andra life science-bolag är redan på plats. Nu flyttar även läkemedelsbolaget Abbvie sitt Sverigekontor till Forskaren i Hagastaden.
-
Specific proposals and targets top the universities’ desired priorities
What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...
-
Topp 20-listor: Sveriges främsta forskare inom molekylär- och mikrobiologi
Mathias Uhlén, Staffan Normark, Joakim Dillner och Carl-Henrik Heldin är namnen som återfinns högst på listorna över Sveriges mest citerade forskare inom mikrob...
-
Medical device quality assurance
Recordings from ZEISS Quality Innovation Days.
-
Astra Zeneca’s asthma drug nears approval for sinus inflammation
Astra Zeneca’s drug Tezspire receives positive opinion from the European Medicines Agency (EMA) for the treatment of chronic rhinosinusitis with nasal polyps.
-
Recipharm divests five Swedish plants
Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...
-
Kris för hajpat genredigeringsbolag – ”Stämningen har skiftat”
Upp som en sol, ner som en pannkaka. Så kan utvecklingen för det upphaussade amerikanska genredigeringsbolaget Tome Biosciences beskrivas.
-
Forskaren in Hagastaden now inagurated
The real estate company Vectura's life science center in Hagastaden, Forskaren, is now inaugurated. The opening was attended by people from the industry, politi...
-
Here are the pharmaceutical companies best prepared for AI
How well prepared are pharmaceutical companies in the field of artificial intelligence? That is what a new analysis has tried to evaluate.
-
Guide: Ställ in en tryckvakt
Här kan du lära dig mer om tryckvakter och hur du ställer in dessa steg för steg, helt själv! I denna korta film får du se hur du ställer in en tryckvakt från v...
-
Science to Market - S2M